Anavex Life Sciences Corp (AVXL) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Anavex Life Sciences Corp   (NASDAQ: AVXL)


Anavex Life Sciences's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Anavex Life Sciences's ROI in the third quarter of 2026?
Anavex Life Sciences Corp recorded a cumulative net loss of $-13 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -12.14%.

Within the Healthcare sector 208 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2714 to 4339.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM -7.41 % -20.97 % -31.14 % -26.46 % -22.08 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 115 123 96 96 92
Return On Investment (TTM) -12.14 % -33.62 % -41.64 % -43.79 % -41.57 %
AVXL's Overall Ranking # 4339 # 2714 # 3219 # 3207 #
Seq. Investment Change TTM 5.8 % 5.71 % -9.42 % -8.61 % -9.7 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -13 -34 -40 -46 -48

AVXL Company Profile >> Back to AVXL Roi Comparisons >> See Annual AVXL Return On Investment



Return On Investment AVXL's Ranking
Within: No.
Industry # 19
Sector # 209
Overall # 4339

Return On Investment Statistics
High Average Low
-12.14 %
-91.31 %
-875.02 %
(Jun 30 2026)   (Mar 31 2014)







Financial Statements
Anavex Life Sciences's III. Quarter Investments $ 115 Millions AVXL's Balance sheet
Anavex Life Sciences's III. Quarter Income $ 8 Millions Quarterly AVXL's Income Statement
AVXL's Income by Division See AVXL's Income by Division


AVXL Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 104 136 154 153 151
Y / Y Investment Growth -23.42 % -12.19 % 1.1 % 0.95 % 455.36 %
Net Income in Millions -46 -43 -48 -48 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -44.67 % -31.72 % -30.77 % -31.42 % 0 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AVXL's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AVXL's Competitors
Subscribers only: Roi for Anavex Life Sciences's Suppliers
Subscribers only: Return On Investment for AVXL's Customers

Other Ratios
AVXL's Roa AVXL's Inventory Turnover Ratio AVXL's Growth Rates AVXL's Dividend Statistics
AVXL's Profitability Ratios AVXL's Asset Turnover Ratio AVXL's Dividend Growth
AVXL's Roe AVXL's Valuation Ratios AVXL's Financial Strength Ratios AVXL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-29T02:43:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.